Breadcrumb

By the Numbers

Image
  • 333 Open Clinical Trials
  • 57 New Clinical Trials
  • 1,351 New Patients
Image
  • 239 Principal Investigators
  • 8 New Faculty Recruits
  • 3 Newly Tenured Investigators
  • 303 Staff Scientists/Staff Clinicians
  • 480 Technical Lab Staff
  • 773 Postdoctoral/Clinical Fellows
  • 401 Postbaccalaureate/Predoctoral Students
Image
  • >1,100 Articles in Peer-Reviewed Journals
Image
  • 52 Technology Facilities and Platforms
Image
Covid
  • >50 COVID-19 Projects
  • >140 COVID-19 Publications

Technology Transfer Activities

Image
Green Reports Icon
  • 63 New Employee Invention Reports
  • 52 Issued U.S. Patents
  • 21 New Cooperative Research and Development Agreements (CRADAs)
  • 9 New Clinical CRADAs
  • 171 Active CRADAs
  • 84 Clinical CRADAs
  • 6 Umbrella CRADAs
  • 24 New Clinical Trial Agreements (CTAs)
  • 105 Active CTAs
Image
Green Licenses Icon
  • 102 New Licenses for CCR Technologies
  • 655 Active Licenses
Image
  • 4 FDA Approvals
  • 1 FDA Orphan Drug Designation

The NCI Technology Transfer Center (TTC) works to enable and guide collaboration, invention development and licensing to advance today’s discoveries into tomorrow’s medical care. The TTC supports technology development activities for NCI in therapeutics, diagnostics, research tools, vaccines, devices, software and facilitates partnerships with outside organizations so that NCI discoveries can reach the public in a timely manner.

For information on licensing and co-development opportunities, contact the TTC Invention Development and Marketing Unit (ncitechtransfer@mail.nih.gov).